The Procter & Gamble Company
Bear Case (25th pct.)
-47.9% vs price
Base Case (Median)
-15.8% vs price
Bull Case (75th pct.)
-9.4% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $281.63 | 94.9% | High (40%) |
| PE Comparable | $121.66 | -15.8% | Medium (25%) |
| Growth Trajectory DCF | $62.92 | -56.5% | Medium (20%) |
| Graham Number | $57.79 | -60.0% | High (80%) |
| EV/EBITDA | $87.74 | -39.3% | Medium (20%) |
| EV/FCF | $131.38 | -9.1% | Medium (20%) |
| Earnings Power Value | $130.47 | -9.7% | High (70%) |
Based on 7 out of 8 methods, PG appears overvalued at the current price of $144.49. The base case fair value of $121.66 implies 15.8% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.